Global Multiple Sclerosis Market, Patient Numbers & Forecast By Mode of Administration – Actual & Unmet (Potential)

Publisher Name :
Date: 15-Sep-2018
No. of pages: 108
Inquire Before Buying

Global Multiple Sclerosis Market, Patient Numbers & Forecast (By Mode of Administration: Injectables Market, Infusions Market, Orals Market) – Actual & Unmet (Potential) published by Renub Research on Multiple Sclerosis Market.

Global multiple sclerosis market is steadily growing and it is expected to cross over US$ 20 Billion landmark by 2022. Multiple sclerosis market is one of the most common neurological disorder diseases in the world.  It is estimated that global multiple sclerosis patient numbers will increase around 35 Thousand by 2022. According to Renub Research analysis, we have found that there is huge gap between actual and unmet market as disease modifying therapy receiving prevalence vary from country to country. Global multiple sclerosis unmet market is much higher compared to its actual market.

Reimbursement is key growth driver for Multiple Sclerosis market globally

Reimbursement is playing major role for the growth of multiple sclerosis market as multiple sclerosis drugs are too expensive and without reimbursement, it is nearly impossible to afford the treatment of MS by most of the multiple sclerosis patient in the world. Most of the European and North American countries have multiple sclerosis reimbursement policy; however eligibility criteria vary from country to country.

Multiple Sclerosis Drugs price is too expensive

Multiple sclerosis drugs price is steadily increasing which create a major challenge for the growth of multiple sclerosis market in the world. It is estimated that newly launched multiple sclerosis drugs are expensive than previous generation disease modifying drugs. According to our research, we have found that, United States multiple sclerosis drugs are nearly five times higher than European multiple sclerosis drugs price.

Injectables Disease Modifying Therapy Multiple Sclerosis Market is losing Ground

Injectables disease modifying therapy multiple sclerosis market is continuously declining. Newly launched orals disease modifying therapy is a growing market.

This 108 page report with 93 figures and 1 Tables provides 6 Countries: actual and potential/unmet patient numbers and market.

This report also explains multiple sclerosis disease modifying therapy (DMT) mode of administration.


  • Actual Market is the current market which is already present

  • Unmet Market is the market which can be accomplished; but it has yet not been accomplished due to demand and supply gap. At present DMT receiving patients are less than total number of multiple sclerosis patient numbers.


6 Countries Multiple Sclerosis Market & Patients Treated Studied in the Report is as Follows:


  • United States

  • United Kingdom  

  • Germany

  • France  

  • Italy

  • Spain


Worldwide and United States Multiple Sclerosis Market & Patients Treated by Mode of administration


  • Injectables

  • Infusions

  • Orals


Key Questions Answered in the Report?   


  • What is multiple sclerosis market globally and its growth potential in Future?

  • How many number of patients treated by disease modifying therapy globally?

  • What is the multiple sclerosis market in United States and other European countries?

  • How many number of multiple sclerosis patients living in United States and other European countries?

Global Multiple Sclerosis Market, Patient Numbers & Forecast By Mode of Administration – Actual & Unmet (Potential)

Table of Contents

1. Research Findings

2. Global Multiple Sclerosis Patient Numbers (2011 – 2022)
2.1 Patient Number & Forecast
2.2 Disease-Modifying Therapy (DMT) Patient Numbers & Forecast
2.3 By Mode of Administration – Injectables, Infusion, Oral Patient Numbers & Forecast
2.3.1 Injectables
2.3.2 Infusions
2.3.3 Orals

3. Global Multiple Sclerosis Market (2011 – 2022)
3.1 Unmet Market & Forecast
3.2 Market & Forecast
3.3 By Mode of Administration - Injectables, Infusions, Orals Market & Forecast
3.3.1 Injectables Market
3.3.2 Infusions Market
3.3.3 Orals Market

4. Patient Share – Global Multiple Sclerosis (2011 – 2022)
4.1 Patient Numbers Share & Forecast – (UK, France, Germany, Italy, Spain & United States)
4.2 Disease-Modifying Therapy (DMT) – (UK, France, Germany, Italy, Spain & United States)
4.3 By Mode of Administration – Injectables, Infusion, Oral

5. Market Share – Global Multiple Sclerosis (2011 – 2022)
5.1 Unmet Market Share & Forecast – (UK, France, Germany, Italy, Spain & United States)
5.2 Market Share & Forecast – (UK, France, Germany, Italy, Spain & United States)
5.3 By Mode of Administration – Injectables, Infusion, Oral

6. United Kingdom
6.1 Multiple Sclerosis Patient Numbers (2011 – 2022)
6.1.1 Patient Number & Forecast
6.1.2 Disease-Modifying Therapy (DMT) Patient Numbers & Forecast
6.2 Multiple Sclerosis Market (2011 – 2022)
6.2.1 Unmet Market & Forecast
6.2.2 Market & Forecast

7. France
7.1 Multiple Sclerosis Patient Number (2011 – 2022)
7.1.1 Patient Number & Forecast
7.1.2 Disease-Modifying Therapy (DMT) Patient Numbers & Forecast
7.2 Multiple Sclerosis Market (2011 – 2022)
7.2.1 Unmet Market & Forecast
7.2.2 Market & Forecast

8. Germany
8.1 Multiple Sclerosis Patient Number (2011 – 2022)
8.1.1 Patient Number & Forecast
8.1.2 Disease-Modifying Therapy (DMT) Patient Numbers & Forecast
8.2 Multiple Sclerosis Market (2011 – 2022)
8.2.1 Unmet Market & Forecast
8.2.2 Market & Forecast

9. Italy
9.1 Multiple Sclerosis Patient Number (2011 – 2022)
9.1.1 Patient Number & Forecast
9.1.2 Disease-Modifying Therapy (DMT) Patient Numbers & Forecast
9.2 Multiple Sclerosis Market (2011 – 2022)
9.2.1 Unmet Market & Forecast
9.2.2 Market & Forecast

10. Spain
10.1 Multiple Sclerosis Patient Number (2011 – 2022)
10.1.1 Patient Number & Forecast
10.1.2 Disease-Modifying Therapy (DMT) Patient Numbers & Forecast
10.2 Multiple Sclerosis Market (2011 – 2022)
10.2.1 Unmet Market & Forecast
10.2.2 Market & Forecast

11. United States
11.1 Multiple Sclerosis Patient Numbers (2011 – 2022)
11.1.1 Patient Number & Forecast
11.1.2 Disease-Modifying Therapy (DMT) Patient Numbers & Forecast
11.2 By Mode of Administration
11.2.1 Injectables Patients Numbers
11.2.2 Infusions Patients Numbers
11.2.3 Orals Patient Numbers
11.3 United States Multiple Sclerosis Market (2011 – 2022)
11.3.1 Unmet Market & Forecast
11.3.2 Market & Forecast
11.4 By Mode of Administration
11.4.1 Injectables Market
11.4.2 Infusions Market
11.4.3 Orals Market

12. Growth Drivers (Due to data confidentiality, growth factors have not been disclosed in this table of contents)
12.1 Point no. 1
12.2 Point no. 2

13. Challenges (Due to data confidentiality, challenges have not been disclosed in this table of contents)
13.1 Point no. 1
13.2 Point no. 2
13.3 Point no. 3

14. Appendix

List of Table

Table 11 1: Europe - Reimbursements for Disease Modifying Drugs (DMDs), 2013

List of Figures

Figure 2‑1: Global - Multiple Sclerosis Patient Numbers (Thousand), 2011 - 2016
Figure 2‑2: Global – Forecast for Multiple Sclerosis Patient Numbers (Thousand), 2017 - 2022
Figure 2‑3: Global - Multiple Sclerosis Disease-Modifying Therapy (DMT) Patient Numbers (Thousand), 2011 - 2016
Figure 2‑4: Global – Forecast for Multiple Sclerosis Disease-Modifying Therapy (DMT) Patient Numbers (Thousand), 2017 - 2022
Figure 2‑5: Global – Multiple Sclerosis Injectables Patient Numbers (Thousand), 2011 – 2016
Figure 2‑6: Global – Forecast for Multiple Sclerosis Injectables Patient Numbers (Thousand), 2017 – 2022
Figure 2‑7: Global - Multiple Sclerosis Infusions Patient Numbers (Thousand), 2011 – 2016
Figure 2‑8: Global – Forecast for Multiple Sclerosis Infusions Patient Numbers (Thousand), 2017 – 2022
Figure 2‑9: Global - Multiple Sclerosis Orals Patient Numbers (Thousand), 2011 – 2016
Figure 2‑10: Global – Forecast for Multiple Sclerosis Orals Patient Numbers (Thousand), 2017 – 2022
Figure 3‑1: Global – Multiple Sclerosis Unmet Market (Billion US$), 2011 – 2016
Figure 3‑2: Global – Forecast for Multiple Sclerosis Unmet Market (Billion US$), 2017 – 2022
Figure 3‑3: Global – Multiple Sclerosis Market (Billion US$), 2011 – 2016
Figure 3‑4: Global – Forecast for Multiple Sclerosis Market (Billion US$), 2017 – 2022
Figure 3‑5: Global – Multiple Sclerosis Injectables Market (Million US$), 2011 – 2016
Figure 3‑6: Global – Forecast for Multiple Sclerosis Injectables Market (Million US$), 2017 – 2022
Figure 3‑7: Global – Multiple Sclerosis Infusions Market (Million US$), 2011 – 2016
Figure 3‑8: Global – Forecast for Multiple Sclerosis Infusions Market (Million US$), 2017 – 2022
Figure 3‑9: Global – Multiple Sclerosis Orals Market (Million US$), 2011 – 2016
Figure 3‑10: Global – Forecast for Multiple Sclerosis Orals Market (Million US$), 2017 – 2022
Figure 4‑1: Global - Patient Numbers Share (Percent), 2011 – 2016
Figure 4‑2: Global – Forecast for Patient Numbers Share (Percent), 2017 – 2022
Figure 4‑3: Global - Disease-Modifying Therapy (DMT) Patient Numbers Share (Percent), 2011 – 2016
Figure 4‑4: Global – Forecast for Disease-Modifying Therapy (DMT) Patient Numbers Share (Percent), 2017 – 2022
Figure 4‑5: Global – Multiple Sclerosis Mode of Administration Patient Numbers Share (Percent), 2011 – 2016
Figure 4‑6: Global – Forecast for Multiple Sclerosis Mode of Administration Patient Numbers Share (Percent), 2017 – 2022
Figure 4‑7: Global – Multiple Sclerosis Unmet Market Share (Percent), 2011 – 2016
Figure 4‑8: Global – Forecast for Multiple Sclerosis Unmet Market Share (Percent), 2017 – 2022
Figure 4‑9: Global – Multiple Sclerosis Market Share (Percent), 2011 – 2016
Figure 4‑10: Global – Forecast for Multiple Sclerosis Market Share (Percent), 2017 – 2022
Figure 4‑11: Global – Multiple Sclerosis Market by Mode of Administration Share (Percent), 2011 – 2016
Figure 4‑12: Global – Forecast for Multiple Sclerosis Market by Mode of Administration Share (Percent), 2017 – 2022
Figure 5‑1: United Kingdom – Multiple Sclerosis Patient Numbers (Thousand), 2011 – 2016
Figure 5‑2: United Kingdom – Forecast for Multiple Sclerosis Patient Numbers (Thousand), 2017 – 2022
Figure 5‑3: United Kingdom – Multiple Sclerosis Disease-Modifying Therapy (DMT) Patient Numbers (Thousand), 2011 – 2016
Figure 5‑4: United Kingdom – Forecast for Multiple Sclerosis Disease-Modifying Therapy (DMT) Patient Numbers (Thousand), 2017 – 2022
Figure 5‑5: United Kingdom – Multiple Sclerosis Unmet Market (Million US$), 2011 – 2016
Figure 5‑6: United Kingdom – Forecast for Multiple Sclerosis Unmet Market (Million US$), 2017 – 2022
Figure 5‑7: United Kingdom – Multiple Sclerosis Market (Million US$), 2011 – 2016
Figure 5‑8: United Kingdom – Forecast for Multiple Sclerosis Market (Million US$), 2017 – 2022
Figure 6‑1: France – Multiple Sclerosis Patient Numbers (Thousand), 2011 – 2016
Figure 6‑2: France – Forecast for Multiple Sclerosis Patient Numbers (Thousand), 2017 – 2022
Figure 6‑3: France – Multiple Sclerosis Disease-Modifying Therapy (DMT) Patient Numbers (Thousand), 2011 – 2016
Figure 6‑4: France – Forecast for Multiple Sclerosis Disease-Modifying Therapy (DMT) Patient Numbers (Thousand), 2017 – 2022
Figure 6‑5: France – Multiple Sclerosis Unmet Market (Million US$), 2011 – 2016
Figure 6‑6: France – Forecast for Multiple Sclerosis Unmet Market (Million US$), 2017 – 2022
Figure 6‑7: France – Multiple Sclerosis Market (Million US$), 2011 – 2016
Figure 6‑8: France – Forecast for Multiple Sclerosis Market (Million US$), 2017 – 2022
Figure 7‑1: Germany – Multiple Sclerosis Patient Numbers (Thousand), 2011 – 2016
Figure 7‑2: Germany – Forecast for Multiple Sclerosis Patient Numbers (Thousand), 2017 – 2022
Figure 7‑3: Germany – Multiple Sclerosis Disease-Modifying Therapy (DMT) Patient Numbers (Thousand), 2011 – 2016
Figure 7‑4: Germany – Forecast for Multiple Sclerosis Disease-Modifying Therapy (DMT) Patient Numbers (Thousand), 2017 – 2022
Figure 7‑5: Germany – Multiple Sclerosis Unmet Market (Million US$), 2011 – 2016
Figure 7‑6: Germany – Forecast for Multiple Sclerosis Unmet Market (Million US$), 2017 – 2022
Figure 7‑7: Germany – Multiple Sclerosis Market (Million US$), 2011 – 2016
Figure 7‑8: Germany – Forecast for Multiple Sclerosis Market (Million US$), 2017 – 2022
Figure 8‑1: Italy – Multiple Sclerosis Patient Numbers (Thousand), 2011 – 2016
Figure 8‑2: Italy – Forecast for Multiple Sclerosis Patient Numbers (Thousand), 2017 – 2022
Figure 8‑3: Italy – Multiple Sclerosis Disease-Modifying Therapy (DMT) Patient Numbers (Thousand), 2011 – 2016
Figure 8‑4: Italy – Forecast for Multiple Sclerosis Disease-Modifying Therapy (DMT) Patient Numbers (Thousand), 2017 – 2022
Figure 8‑5: Italy – Multiple Sclerosis Unmet Market (Million US$), 2011 – 2016
Figure 8‑6: Italy – Forecast for Multiple Sclerosis Unmet Market (Million US$), 2017 – 2022
Figure 8‑7: Italy – Multiple Sclerosis Market (Million US$), 2011 – 2016
Figure 8‑8: Italy – Forecast for Multiple Sclerosis Market (Million US$), 2017 – 2022
Figure 9‑1: Spain – Multiple Sclerosis Patient Numbers (Thousand), 2011 – 2016
Figure 9‑2: Spain – Forecast for Multiple Sclerosis Patient Numbers (Thousand), 2017 – 2022
Figure 9‑3: Spain – Multiple Sclerosis Disease-Modifying Therapy (DMT) Patient Numbers (Thousand), 2011 – 2016
Figure 9‑4: Spain – Forecast for Multiple Sclerosis Disease-Modifying Therapy (DMT) Patient Numbers (Thousand), 2017 – 2022
Figure 9‑5: Spain – Multiple Sclerosis Unmet Market (Million US$), 2011 – 2016
Figure 9‑6: Spain – Forecast for Multiple Sclerosis Unmet Market (Million US$), 2017 – 2022
Figure 9‑7: Spain – Multiple Sclerosis Market (Million US$), 2011 – 2016
Figure 9‑8: Spain – Forecast for Multiple Sclerosis Market (Million US$), 2017 – 2022
Figure 10‑1: United States – Multiple Sclerosis Patient Numbers (Thousand), 2011 – 2016
Figure 10‑2: United States – Forecast for Multiple Sclerosis Patient Numbers (Thousand), 2017 – 2022
Figure 10‑3: United States – Multiple Sclerosis Disease-Modifying Therapy (DMT) Patient Numbers (Thousand), 2011 – 2016
Figure 10‑4: United States – Forecast for Multiple Sclerosis Disease-Modifying Therapy (DMT) Patient Numbers (Thousand), 2017 – 2022
Figure 10‑5: United States – Multiple Sclerosis Injectables Patient Numbers (Thousand), 2011 – 2016
Figure 10‑6: United States – Forecast for Multiple Sclerosis Injectables Patient Numbers (Thousand), 2017 – 2022
Figure 10‑7: United States - Multiple Sclerosis Infusions Patient Numbers (Thousand), 2011 – 2016
Figure 10‑8: United States – Forecast for Multiple Sclerosis Infusions Patient Numbers (Thousand), 2017 – 2022
Figure 10‑9: United States - Multiple Sclerosis Orals Patient Numbers (Thousand), 2011 – 2016
Figure 10‑10: United States – Forecast for Multiple Sclerosis Orals Patient Numbers (Thousand), 2017 – 2022
Figure 10‑11: United States – Multiple Sclerosis Unmet Market (Billion US$), 2011 – 2016
Figure 10‑12: United States – Forecast for Multiple Sclerosis Unmet Market (Billion US$), 2017 – 2022
Figure 10‑13: United States – Multiple Sclerosis Market (Billion US$), 2011 – 2016
Figure 10‑14: United States – Forecast for Multiple Sclerosis Market (Billion US$), 2017 – 2022
Figure 10‑15: United States – Multiple Sclerosis Injectables Market (Million US$), 2011 – 2016
Figure 10‑16: United States – Forecast for Multiple Sclerosis Injectables Market (Million US$), 2017 – 2022
Figure 10‑17: United States – Multiple Sclerosis Infusions Market (Million US$), 2011 – 2016
Figure 10‑18: United States – Forecast for Multiple Sclerosis Infusions Market (Million US$), 2017 – 2022
Figure 10‑19: United States – Multiple Sclerosis Orals Market (Million US$), 2011 – 2016
Figure 10‑20: United States – Forecast for Multiple Sclerosis Orals Market (Million US$), 2017 – 2022
Figure 12‑1: Europe - Number of Neurologists per 100,000 Specialized in MS vs. Percent of MS Population Receiving DMDs, 2013

  • Global Lip Fillers Sales Market Report 2021
    Published: 10-May-2021        Price: US 4000 Onwards        Pages: 132
    The global Lip Fillers market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Lip Fillers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Hyaluronic Acid Lip Fillers - Poly Lactic Acid Lip Fi......
  • Global Phosphate Binders Sales Market Report 2021
    Published: 10-May-2021        Price: US 4000 Onwards        Pages: 145
    The global Phosphate Binders market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Phosphate Binders market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Calcium Carbonate - Calcium Acetate......
  • Global Peptide APIs Sales Market Report 2021
    Published: 10-May-2021        Price: US 4000 Onwards        Pages: 132
    The global Peptide APIs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Peptide APIs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Liquid Phase Peptide Synthesis (LPPS) - Solid Phase......
  • Global Small Molecule API Sales Market Report 2021
    Published: 10-May-2021        Price: US 4000 Onwards        Pages: 148
    The global Small Molecule API market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Small Molecule API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Synthetic & Chemical API - Biological A......
  • Global Specialty Active Pharmaceutical Ingredients Sales Market Report 2021
    Published: 10-May-2021        Price: US 4000 Onwards        Pages: 130
    The global Specialty Active Pharmaceutical Ingredients market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Specialty Active Pharmaceutical Ingredients market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type......
  • Global Preventive Vaccines Sales Market Report 2021
    Published: 10-May-2021        Price: US 4000 Onwards        Pages: 135
    The global Preventive Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Preventive Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Intramuscular Injection - Nasal Spray......
  • Global Dental Anesthesia Sales Market Report 2021
    Published: 10-May-2021        Price: US 4000 Onwards        Pages: 141
    The global Dental Anesthesia market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Dental Anesthesia market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Local Anesthesia - General Anesthesia......
  • Global OTC for Kids Sales Market Report 2021
    Published: 10-May-2021        Price: US 4000 Onwards        Pages: 145
    The global OTC for Kids market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global OTC for Kids market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Gastrointestinal Tract - Dermatology - Otola......
  • Global Cold Pressed Citrus Oil Sales Market Report 2021
    Published: 10-May-2021        Price: US 4000 Onwards        Pages: 143
    The global Cold Pressed Citrus Oil market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cold Pressed Citrus Oil market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Oranges Source - Tangerines/M......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs